---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-24-001346"
form_type: "8-K"
ticker: "LEXX"
cik: "0001348362"
company_name: "Lexaria Bioscience Corp."
filed_at: "2024-08-22T23:59:59+00:00"
generated_at: "2026-05-31T08:02:22.571152+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Lexaria Bioscience enters $20M at-the-market equity sales agreement with JonesTrading

## Summary
- Up to $20M of common stock may be sold from time to time through Agent JonesTrading as ATM offering.
- Agent will receive 3.0% commission on gross sales price; Company reimburses certain expenses.
- Shares sold under previously effective shelf registration statement (File No. 333-262402).
- Agreement terminates upon sale of all Shares or earlier termination by either party.
- No assurance any Shares will be issued; proceeds used for general corporate purposes.

## SEC filing metadata
- accession: 0001640334-24-001346
- form_type: 8-K
- ticker: LEXX
- cik: 0001348362
- company_name: Lexaria Bioscience Corp.
- filed_at: 2024-08-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1348362/000164033424001346/0001640334-24-001346-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1348362/000164033424001346/lxrp_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-24-001346
- JSON: https://secwatch.observer/filing/0001640334-24-001346.json
- Plain text: https://secwatch.observer/filing/0001640334-24-001346.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.